Wobe Mugos E® (Wobe-mugos E®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspenteric coated tablets
Composition:Chymotrypsin 40 mg, trypsin 40 mg, papain 100 mg, lactose,microcrystalline cellulose, macrogol 6000, copovidone, magnesium stearate, silicon dioxide anhydrous, povidone, crospovidone, methacrylic acid-methyl methacrylate copolymer (1: 1), talc, triethyl citrate, vanillin.
Description:Round, biconvex tablets covered with a coat, white with gray or white with a cream shade of color with a characteristic smell.
Pharmacotherapeutic group:Enzyme agent
ATX: & nbsp
  • Other immunostimulants
    • Pharmacodynamics:Enzymes (enzymes) are involved in the implementation of virtually all processes of life.

    VOBE-MUGOS E® is a combination of highly active natural enzymes of animal and vegetable origin. Has immunomodulatory, fibrinolytic, anti-inflammatory action. Activates antiviral immunity (NK cells, cytotoxic T-lymphocytes, macrophages) and regulates the cytokine system. Reduces the negative impact of radiation and chemotherapy on the body.

    Splits immune complexes and promotes their elimination by stimulating phagocytic activity of macrophages.

    Improves the rheological properties of blood and microcirculation, which contributes to the elimination of toxic products and the improvement of tissue trophism.

    Indications:Treatment of herpes infections:

    - Shingles, herpes simple, as well as their recurring forms.

    In complex therapy as an adjuvant to reduce the side effects of chemo and radiation therapy.

    Contraindications:Diseases accompanied by disorders of blood clotting (hemophilia), as well as during hemodialysis.
    Carefully:During pregnancy.
    Dosing and Administration:Tablets should be taken at least 30 minutes before meals, without chewing, washing with water (150-200 ml).

    When treating viral diseases, it is recommended to take 3-5 tablets 3 times a day until the main clinical symptoms disappear. In severe herpetic infection the drug should be taken 5 tablets 3 times a day for 2-4 weeks or more until the disappearance of the main clinical symptoms. The duration of treatment is determined by the doctor individually. On the first day of taking the drug, the recommended dose is 2 tablets 3 times a day.

    Attention !

    Treatment should be started as soon as possible - with the appearance of the first symptoms of a viral infection.

    During the course of chemotherapy or radiation therapy, it is recommended to take 3 tablets 3 times a day during the entire course of therapy. If necessary, the dose of the drug can be increased to 5 tablets 3 times a day.

    Side effects:VOBE-MUGOS E® is usually well tolerated by patients, no side effects were observed even with prolonged treatment with high doses. In some cases, there is a lighter coloration of the stool, a change in odor and consistency. When taking high doses of the drug, sometimes there is a sensation of bloating, and a quickening of the stool. In these cases, the drug should not be discontinued, a temporary dose reduction is recommended.
    Overdose:Cases of drug overdose are unknown.
    Interaction:With simultaneous administration with other drugs, incompatibility cases are not known.
    Special instructions:At the very beginning of treatment with the drug, the symptoms of the disease can worsen, which should be regarded as the reaction of the body to therapy. In such cases, the drug should not be discontinued, a temporary dose reduction is recommended.

    The drug does not have a negative impact on driving and performance of works requiring high speed of mental and physical reactions.

    Form release / dosage:Tablets, covered with enteric coating.
    Packaging:Blisters of 20 pcs., In boxes contains 20, 40 and 100 pcs. with instructions for medical use.
    Storage conditions:In a dry place at a temperature of 15-25 °C, out of the reach of children. List B.
    Shelf life:2 years. Do not use after the time specified on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:П N015522 / 01
    Date of registration:09.02.2009
    Expiration Date:Unlimited
    The owner of the registration certificate:MUKOS PHARMA GmbH & Co. MUKOS PHARMA GmbH & Co. Germany
    Manufacturer: & nbsp
    Representation: & nbspMUKOS PHARMA GmbH & Co. MUKOS PHARMA GmbH & Co. Germany
    Information update date: & nbsp28.02.2017
    Illustrated instructions
      Instructions
      Up